ID   KAT7_HUMAN              Reviewed;         611 AA.
AC   O95251; B3KN74; B4DF85; B4DFB4; B4DFE0; B4DGY4; E7ER15; G5E9K7;
DT   05-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   10-MAY-2017, entry version 156.
DE   RecName: Full=Histone acetyltransferase KAT7;
DE            EC=2.3.1.48 {ECO:0000269|PubMed:10438470};
DE   AltName: Full=Histone acetyltransferase binding to ORC1;
DE   AltName: Full=Lysine acetyltransferase 7;
DE   AltName: Full=MOZ, YBF2/SAS3, SAS2 and TIP60 protein 2;
DE            Short=MYST-2;
GN   Name=KAT7; Synonyms=HBO1, HBOa, MYST2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INTERACTION WITH ORC1,
RP   FUNCTION, CATALYTIC ACTIVITY, AND TISSUE SPECIFICITY.
RC   TISSUE=Epithelium;
RX   PubMed=10438470; DOI=10.1074/jbc.274.33.23027;
RA   Iizuka M., Stillman B.;
RT   "Histone acetyltransferase HBO1 interacts with the ORC1 subunit of the
RT   human initiator protein.";
RL   J. Biol. Chem. 274:23027-23034(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY,
RP   SUBCELLULAR LOCATION, INTERACTION WITH AR, AND FUNCTION.
RC   TISSUE=Prostate;
RX   PubMed=10930412; DOI=10.1074/jbc.M004838200;
RA   Sharma M., Zarnegar M., Li X., Lim B., Sun Z.;
RT   "Androgen receptor interacts with a novel MYST protein, HBO1.";
RL   J. Biol. Chem. 275:35200-35208(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Jian J., Guangtao L., Guangwei D., Yan Z., Jianhe C., Jiangang Y.,
RA   Boqin Q.;
RT   "Cloning and identifying histone acetyltransferase HBOa.";
RL   Submitted (APR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Borrow J., Housman D.E.;
RT   "Structure and function of the human MYST family: MOZ2, MYST1 and
RT   MYST2.";
RL   Submitted (DEC-1999) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2; 3; 4 AND 5).
RC   TISSUE=Brain, Cerebellum, and Thyroid;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   INTERACTION WITH MCM2 AND ORC1, DOMAIN, SUBCELLULAR LOCATION,
RP   FUNCTION, AND MUTAGENESIS OF CYS-371.
RX   PubMed=11278932; DOI=10.1074/jbc.M011556200;
RA   Burke T.W., Cook J.G., Asano M., Nevins J.R.;
RT   "Replication factors MCM2 and ORC1 interact with the histone
RT   acetyltransferase HBO1.";
RL   J. Biol. Chem. 276:15397-15408(2001).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [11]
RP   FUNCTION IN HISTONE ACETYLATION, FUNCTION IN DNA REPLICATION, FUNCTION
RP   IN TP53-MEDIATED TRANSCRIPTION, IDENTIFICATION IN THE HBO1 COMPLEX,
RP   INTERACTION WITH MCM2, AND SUBCELLULAR LOCATION.
RX   PubMed=16387653; DOI=10.1016/j.molcel.2005.12.007;
RA   Doyon Y., Cayrou C., Ullah M., Landry A.-J., Cote V., Selleck W.,
RA   Lane W.S., Tan S., Yang X.-J., Cote J.;
RT   "ING tumor suppressor proteins are critical regulators of chromatin
RT   acetylation required for genome expression and perpetuation.";
RL   Mol. Cell 21:51-64(2006).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-88, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [14]
RP   INTERACTION WITH CDT1, AND SUBCELLULAR LOCATION.
RX   PubMed=18832067; DOI=10.1101/gad.1674108;
RA   Miotto B., Struhl K.;
RT   "HBO1 histone acetylase is a coactivator of the replication licensing
RT   factor Cdt1.";
RL   Genes Dev. 22:2633-2638(2008).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-50; SER-57; THR-85;
RP   THR-88 AND SER-102, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [16]
RP   PHOSPHORYLATION AT SER-57 BY PLK1, AND PHOSPHORYLATION AT THR-85 AND
RP   THR-88 BY CDK1.
RX   PubMed=18250300; DOI=10.1073/pnas.0712063105;
RA   Wu Z.Q., Liu X.;
RT   "Role for Plk1 phosphorylation of Hbo1 in regulation of replication
RT   licensing.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:1919-1924(2008).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-57; THR-85; THR-88 AND
RP   SER-102, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [19]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-199, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-162 AND SER-506, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-57; THR-88; SER-102;
RP   SER-124; SER-162 AND SER-164, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-10; SER-50; SER-57;
RP   SER-64; SER-102; SER-111; SER-162; SER-164; SER-178 AND SER-506, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-158, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Component of the HBO1 complex which has a histone H4-
CC       specific acetyltransferase activity, a reduced activity toward
CC       histone H3 and is responsible for the bulk of histone H4
CC       acetylation in vivo. Through chromatin acetylation it may regulate
CC       DNA replication and act as a coactivator of TP53-dependent
CC       transcription. Acts as a coactivator of the licensing factor CDT1
CC       (PubMed:18832067). Specifically represses AR-mediated
CC       transcription. {ECO:0000269|PubMed:10438470,
CC       ECO:0000269|PubMed:10930412, ECO:0000269|PubMed:11278932,
CC       ECO:0000269|PubMed:16387653, ECO:0000269|PubMed:18832067}.
CC   -!- CATALYTIC ACTIVITY: Acetyl-CoA + [protein]-L-lysine = CoA +
CC       [protein]-N(6)-acetyl-L-lysine. {ECO:0000269|PubMed:10438470}.
CC   -!- SUBUNIT: Component of the HBO1 complex composed at least of ING4
CC       or ING5, KAT7/HBO1, MEAF6, and one of JADE1, JADE2 and JADE3.
CC       Interacts with MCM2 and ORC1. Interacts with the androgen receptor
CC       (AR) in the presence of dihydrotestosterone (PubMed:10930412).
CC       Interacts with CDT1 (PubMed:18832067).
CC       {ECO:0000269|PubMed:10438470, ECO:0000269|PubMed:10930412,
CC       ECO:0000269|PubMed:11278932, ECO:0000269|PubMed:16387653,
CC       ECO:0000269|PubMed:18832067}.
CC   -!- INTERACTION:
CC       P10275:AR; NbExp=5; IntAct=EBI-473199, EBI-608057;
CC       Q99728:BARD1; NbExp=2; IntAct=EBI-473199, EBI-473181;
CC       Q9P2H0:CEP126; NbExp=2; IntAct=EBI-473199, EBI-473176;
CC       P08670:VIM; NbExp=4; IntAct=EBI-473199, EBI-353844;
CC   -!- SUBCELLULAR LOCATION: Nucleus, nucleoplasm
CC       {ECO:0000269|PubMed:10930412, ECO:0000269|PubMed:11278932,
CC       ECO:0000269|PubMed:16387653}. Note=Associates with replication
CC       origins specifically during the G1 phase of the cell cycle
CC       (PubMed:18832067). {ECO:0000269|PubMed:18832067}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=O95251-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O95251-2; Sequence=VSP_042553, VSP_042554;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=O95251-3; Sequence=VSP_042552, VSP_042553, VSP_042554;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=O95251-4; Sequence=VSP_042554;
CC         Note=No experimental confirmation available.;
CC       Name=5;
CC         IsoId=O95251-5; Sequence=VSP_042552, VSP_042553;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed, with highest levels in
CC       testis. {ECO:0000269|PubMed:10438470,
CC       ECO:0000269|PubMed:10930412}.
CC   -!- DOMAIN: The C2HC MYST-type zinc finger is required for interaction
CC       with MCM2 and ORC1. {ECO:0000269|PubMed:11278932}.
CC   -!- DOMAIN: The N-terminus is involved in transcriptional repression,
CC       while the C-terminus mediates AR-interaction. {ECO:0000250}.
CC   -!- PTM: Phosphorylation at Ser-57 by PLK1 during mitosis seems
CC       important for prereplicative complex formation and DNA replication
CC       licensing, and requires prior phosphorylation at Thr-85 and Thr-88
CC       by CDK1 (PubMed:18250300). {ECO:0000269|PubMed:18250300}.
CC   -!- PTM: Autoacetylation at Lys-432 is required for proper function.
CC       {ECO:0000250|UniProtKB:Q9H7Z6}.
CC   -!- SIMILARITY: Belongs to the MYST (SAS/MOZ) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF074606; AAC99368.1; -; mRNA.
DR   EMBL; AF140360; AAD42348.1; -; mRNA.
DR   EMBL; AF217502; AAL56649.1; -; mRNA.
DR   EMBL; AK023890; BAG51236.1; -; mRNA.
DR   EMBL; AK293976; BAG57346.1; -; mRNA.
DR   EMBL; AK294014; BAG57375.1; -; mRNA.
DR   EMBL; AK294052; BAG57401.1; -; mRNA.
DR   EMBL; AK294836; BAG57945.1; -; mRNA.
DR   EMBL; AC015795; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC027801; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471109; EAW94658.1; -; Genomic_DNA.
DR   EMBL; CH471109; EAW94659.1; -; Genomic_DNA.
DR   EMBL; BC032640; AAH32640.1; -; mRNA.
DR   CCDS; CCDS11554.1; -. [O95251-1]
DR   CCDS; CCDS56035.1; -. [O95251-4]
DR   CCDS; CCDS56036.1; -. [O95251-2]
DR   CCDS; CCDS56037.1; -. [O95251-5]
DR   CCDS; CCDS56038.1; -. [O95251-3]
DR   RefSeq; NP_001186084.1; NM_001199155.1. [O95251-4]
DR   RefSeq; NP_001186085.1; NM_001199156.1. [O95251-5]
DR   RefSeq; NP_001186086.1; NM_001199157.1. [O95251-2]
DR   RefSeq; NP_001186087.1; NM_001199158.1. [O95251-3]
DR   RefSeq; NP_008998.1; NM_007067.4. [O95251-1]
DR   UniGene; Hs.21907; -.
DR   PDB; 5GK9; X-ray; 2.40 A; A=336-611.
DR   PDBsum; 5GK9; -.
DR   ProteinModelPortal; O95251; -.
DR   SMR; O95251; -.
DR   BioGrid; 116315; 67.
DR   DIP; DIP-29697N; -.
DR   IntAct; O95251; 43.
DR   MINT; MINT-141769; -.
DR   STRING; 9606.ENSP00000259021; -.
DR   iPTMnet; O95251; -.
DR   PhosphoSitePlus; O95251; -.
DR   BioMuta; KAT7; -.
DR   EPD; O95251; -.
DR   MaxQB; O95251; -.
DR   PaxDb; O95251; -.
DR   PeptideAtlas; O95251; -.
DR   PRIDE; O95251; -.
DR   DNASU; 11143; -.
DR   Ensembl; ENST00000259021; ENSP00000259021; ENSG00000136504. [O95251-1]
DR   Ensembl; ENST00000424009; ENSP00000398961; ENSG00000136504. [O95251-4]
DR   Ensembl; ENST00000454930; ENSP00000413415; ENSG00000136504. [O95251-5]
DR   Ensembl; ENST00000509773; ENSP00000424577; ENSG00000136504. [O95251-2]
DR   Ensembl; ENST00000510819; ENSP00000423385; ENSG00000136504. [O95251-3]
DR   GeneID; 11143; -.
DR   KEGG; hsa:11143; -.
DR   UCSC; uc002ipl.3; human. [O95251-1]
DR   CTD; 11143; -.
DR   DisGeNET; 11143; -.
DR   GeneCards; KAT7; -.
DR   HGNC; HGNC:17016; KAT7.
DR   HPA; HPA044470; -.
DR   MIM; 609880; gene.
DR   neXtProt; NX_O95251; -.
DR   OpenTargets; ENSG00000136504; -.
DR   PharmGKB; PA134886407; -.
DR   eggNOG; KOG2747; Eukaryota.
DR   eggNOG; COG5027; LUCA.
DR   GeneTree; ENSGT00550000074503; -.
DR   HOGENOM; HOG000182457; -.
DR   HOVERGEN; HBG053268; -.
DR   InParanoid; O95251; -.
DR   KO; K11307; -.
DR   OMA; VYSTRRV; -.
DR   OrthoDB; EOG091G00D2; -.
DR   PhylomeDB; O95251; -.
DR   TreeFam; TF317619; -.
DR   Reactome; R-HSA-3214847; HATs acetylate histones.
DR   SIGNOR; O95251; -.
DR   GeneWiki; MYST2; -.
DR   GenomeRNAi; 11143; -.
DR   PRO; PR:O95251; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000136504; -.
DR   CleanEx; HS_MYST2; -.
DR   ExpressionAtlas; O95251; baseline and differential.
DR   Genevisible; O95251; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0000123; C:histone acetyltransferase complex; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:GO_Central.
DR   GO; GO:0003688; F:DNA replication origin binding; IMP:CAFA.
DR   GO; GO:0004402; F:histone acetyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0044212; F:transcription regulatory region DNA binding; IMP:CAFA.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006260; P:DNA replication; IDA:UniProtKB.
DR   GO; GO:0043966; P:histone H3 acetylation; IDA:UniProtKB.
DR   GO; GO:0043983; P:histone H4-K12 acetylation; IDA:UniProtKB.
DR   GO; GO:0043981; P:histone H4-K5 acetylation; IDA:UniProtKB.
DR   GO; GO:0043982; P:histone H4-K8 acetylation; IDA:UniProtKB.
DR   GO; GO:0090240; P:positive regulation of histone H4 acetylation; IMP:CAFA.
DR   GO; GO:1900182; P:positive regulation of protein localization to nucleus; IDA:GO_Central.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:CAFA.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; TAS:ProtInc.
DR   GO; GO:0072716; P:response to actinomycin D; IMP:CAFA.
DR   GO; GO:0072739; P:response to anisomycin; IMP:CAFA.
DR   GO; GO:0072720; P:response to dithiothreitol; IMP:CAFA.
DR   GO; GO:0072710; P:response to hydroxyurea; IMP:CAFA.
DR   GO; GO:0072708; P:response to sorbitol; IMP:CAFA.
DR   GO; GO:0031098; P:stress-activated protein kinase signaling cascade; IDA:CAFA.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   InterPro; IPR016181; Acyl_CoA_acyltransferase.
DR   InterPro; IPR002717; HAT_MYST-type.
DR   InterPro; IPR002515; Znf_C2HC.
DR   Pfam; PF01853; MOZ_SAS; 1.
DR   Pfam; PF01530; zf-C2HC; 1.
DR   SUPFAM; SSF103637; SSF103637; 1.
DR   SUPFAM; SSF55729; SSF55729; 1.
DR   PROSITE; PS51726; MYST_HAT; 1.
DR   PROSITE; PS51802; ZF_CCHHC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Acyltransferase; Alternative splicing;
KW   Chromatin regulator; Complete proteome; DNA replication;
KW   Metal-binding; Nucleus; Phosphoprotein; Reference proteome;
KW   Transcription; Transcription regulation; Transferase; Zinc;
KW   Zinc-finger.
FT   CHAIN         1    611       Histone acetyltransferase KAT7.
FT                                /FTId=PRO_0000051569.
FT   DOMAIN      332    607       MYST-type HAT. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01063}.
FT   ZN_FING     176    219       CCHHC-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01143}.
FT   ZN_FING     365    390       C2HC MYST-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01063}.
FT   REGION      475    477       Acetyl-CoA binding.
FT                                {ECO:0000250|UniProtKB:Q9H7Z6}.
FT   REGION      482    488       Acetyl-CoA binding.
FT                                {ECO:0000250|UniProtKB:Q9H7Z6}.
FT   COMPBIAS     10     57       Ser-rich.
FT   ACT_SITE    508    508       Proton donor/acceptor.
FT                                {ECO:0000250|UniProtKB:Q9H7Z6}.
FT   BINDING     512    512       Acetyl-CoA.
FT                                {ECO:0000250|UniProtKB:Q9H7Z6}.
FT   BINDING     521    521       Acetyl-CoA.
FT                                {ECO:0000250|UniProtKB:Q9H7Z6}.
FT   MOD_RES      10     10       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      50     50       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      57     57       Phosphoserine; by PLK1.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:18250300}.
FT   MOD_RES      64     64       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      85     85       Phosphothreonine; by CDK1.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000269|PubMed:18250300}.
FT   MOD_RES      88     88       Phosphothreonine; by CDK1.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000269|PubMed:18250300}.
FT   MOD_RES     102    102       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     104    104       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q5SVQ0}.
FT   MOD_RES     111    111       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     124    124       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     128    128       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q5SVQ0}.
FT   MOD_RES     158    158       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     162    162       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     164    164       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     178    178       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     199    199       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     277    277       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q5SVQ0}.
FT   MOD_RES     432    432       N6-acetyllysine; by autocatalysis.
FT                                {ECO:0000250|UniProtKB:Q9H7Z6}.
FT   MOD_RES     506    506       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ      55    113       Missing (in isoform 3 and isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_042552.
FT   VAR_SEQ     114    193       Missing (in isoform 2, isoform 3 and
FT                                isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_042553.
FT   VAR_SEQ     222    251       Missing (in isoform 2, isoform 3 and
FT                                isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_042554.
FT   MUTAGEN     371    371       C->A: No interaction with MCM2 and ORC1.
FT                                {ECO:0000269|PubMed:11278932}.
FT   CONFLICT     38     44       Missing (in Ref. 5; BAG57945).
FT                                {ECO:0000305}.
FT   CONFLICT     41     41       R -> Q (in Ref. 5; BAG57346).
FT                                {ECO:0000305}.
SQ   SEQUENCE   611 AA;  70642 MW;  8368E7C4F07D8D7C CRC64;
     MPRRKRNAGS SSDGTEDSDF STDLEHTDSS ESDGTSRRSA RVTRSSARLS QSSQDSSPVR
     NLQSFGTEEP AYSTRRVTRS QQQPTPVTPK KYPLRQTRSS GSETEQVVDF SDRETKNTAD
     HDESPPRTPT GNAPSSESDI DISSPNVSHD ESIAKDMSLK DSGSDLSHRP KRRRFHESYN
     FNMKCPTPGC NSLGHLTGKH ERHFSISGCP LYHNLSADEC KVRAQSRDKQ IEERMLSHRQ
     DDNNRHATRH QAPTERQLRY KEKVAELRKK RNSGLSKEQK EKYMEHRQTY GNTREPLLEN
     LTSEYDLDLF RRAQARASED LEKLRLQGQI TEGSNMIKTI AFGRYELDTW YHSPYPEEYA
     RLGRLYMCEF CLKYMKSQTI LRRHMAKCVW KHPPGDEIYR KGSISVFEVD GKKNKIYCQN
     LCLLAKLFLD HKTLYYDVEP FLFYVMTEAD NTGCHLIGYF SKEKNSFLNY NVSCILTMPQ
     YMRQGYGKML IDFSYLLSKV EEKVGSPERP LSDLGLISYR SYWKEVLLRY LHNFQGKEIS
     IKEISQETAV NPVDIVSTLQ ALQMLKYWKG KHLVLKRQDL IDEWIAKEAK RSNSNKTMDP
     SCLKWTPPKG T
//
